Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

New UK data shows RSV vaccines in pregnant women cut infant hospitalizations by 72%, while premature babies are now protected ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally.A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

RSV vaccines aren't needed every year. Federal regulators recommend a single dose of RSV vaccine, so If you were vaccinated last year, you won't need another dose this year.

A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and ...

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information. Hotspots ranked Start the day smarter ☀️ Funniest cap ...

A vaccine to protect infants in their first six months of life — the age group at highest risk of being hospitalized with RSV — is expected to gain FDA approval later this year.

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.